Perspective Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
AMEX
Lantheus Holdings, Inc. and its subsidiaries have significantly reduced their beneficial ownership in Perspective Therapeutics, Inc., selling over 8.7 million shares.
AMEX
Lantheus Holdings, Inc. and its subsidiaries have reported the sale of over 236,000 shares of Perspective Therapeutics, Inc. common stock, reducing their beneficial ownership to 10.0%.